Project description
Artificial intelligence to assist in skin cancer screening
Malignant melanoma originates in the skin's melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of metastases. Early detection of melanoma has a 98 % survival rate, but late detection results only in a 10-25 % survival rate. People at high risk of developing skin cancer have to regularly monitor their skin and moles for changes as early detection is so critical for successful treatment. The EU has provided funding to Miiskin Aps for the development of a supporting tool to assist in the screening and monitoring of skin changes over time with an innovative AI-based application. The novel application will make the monitoring process more efficient and reliable, improving screening of mole changes through automatic photo comparison and unlocking possibilities for teledermatology.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
2100 København O
Denmark
See on map